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Quorum sensing triggers virulence factor expression in medically
important bacterial pathogens in response to a density-dependent
increase in one or more autoinducing pheromones. Here, we show
that phagocyte-derived oxidants target these autoinducers for
inactivation as an innate defense mechanism of the host. In a skin
infection model, expression of phagocyte NADPH oxidase, myelo-
peroxidase, or inducible nitric oxide synthase was critical for
defense against a quorum-sensing pathogen, Staphylococcus
aureus, but not for defense against a quorum sensing-deficient
mutant. A virulence-inducing peptide of S. aureus was inactivated
in vitro and in vivo by reactive oxygen and nitrogen intermediates,
including HOCl and ONOO. Inactivation of the autoinducer pre-
vented both the up-regulation of virulence gene expression and
the downstream sequelae. MS analysis of the inactivated peptide
demonstrated that oxidation of the C-terminal methionine was
primarily responsible for loss of activity. Treatment of WT but not
NADPH oxidase-deficient mice with N-acetyl methionine to scav-
enge the inhibitory oxidants increased in vivo quorum sensing
independently of the bacterial burden at the site of infection. Thus,
oxidant-mediated inactivation of an autoinducing peptide from S.
aureus is a critical innate defense mechanism against infection with
this pathogen.
Bacteria sense each other and their numbers by means of acell-to-cell communication mechanism, called quorum sens-
ing, that is mediated by secretion of small, diffusible pheromones
or autoinducers (1, 2). At a concentration threshold that reflects
a sufficient quorum of bacteria, the autoinducers trigger behav-
iors that are primarily effective at high population densities,
including the secretion of virulence factors (1–6). Whereas the
genetic systems that regulate quorum sensing in many bacterial
pathogens are undergoing intensive investigation, specific effec-
tor mechanisms in mammalian hosts that limit density-
dependent virulence have not been defined. We speculated that
an important contribution of innate immunity in defense against
bacterial infection would be to inhibit autoinducer signaling of
virulence gene expression.
Staphylococcus aureus is a medically important bacterial
pathogen that uses quorum sensing to regulate virulence in
several experimental models of infection (4, 7–9). The agr
operon, which is responsible in part for this regulation, combines
secretion of an autoinducing thiolactone peptide (AIP) with a
two-component regulatory pathway to generate a regulatory
RNA transcript, RNAIII, that is the effector of the operon
(10–12). S. aureus strains can be categorized into four groups
based on the amino acid sequence of the AIP produced (12).
Whereas clinical isolates are enriched for the type I AIP (13, 14),
all groups are represented in human disease (14). Under con-
ditions of high AIP concentration, i.e., high bacterial density,
RNAIII down-regulates gene expression encoding for surface
adhesins while up-regulating those encoding for capsule produc-
tion, secreted toxins, proteases, and metabolic pathways (10, 12,
15). This conversion in phenotype from adhesive and colonizing
to tissue-damaging and invasive is thought to contribute to the
pathogenesis of systemic infection (10, 12, 16).
The phagocyte NADPH oxidase is an important innate
effector against this pathogen, and humans and mice that lack
this enzyme are more susceptible to staphylococcal infection
(17–19). Activation of the NADPH oxidase could contribute to
host defense against S. aureus in many ways, from direct (20)
and indirect (21) bacterial killing to regulating gene transcrip-
tion of inf lammatory mediators (22). We hypothesized that
phagocyte-derived oxidants act additionally as a barrier
against density-dependent virulence by inactivating the pher-
omone autoinducers. Here, we show that phagocyte-derived
oxidants contribute to innate immunity by inhibiting patho-
genic bacterial communication.
Materials and Methods
Mice. C57BL6 mice (8–16 wk, 20–25 g) from Charles River
Breeding Laboratories, NADPH oxidase (gp91phox)/ and in-
ducible NO synthase (INOS)/mice from The Jackson Labo-
ratory, and myeloperoxidase (MPO)/ mice (23) on the
C57BL6 background were gender- and age-matched. The ap-
propriate institutional committees approved all experiments.
Bacteria. AIP group I WT RN6390, its agr deleted mutant
RN6911, and AIP group I methicillin-resistant S. aureus
(MRSA) COL strains containing plasmids encoding the pro-
moter for RNAIII or  hemolysin (hla) driving expression of
GFP were generated as described (24). Early exponential phase,
nonfluorescent bacteria with a mean channel of fluorescence
(MCF) of 10–20 by flow cytometry (FACSCalibur, Becton
Dickinson) were prepared as described (7). Culture supernatants
from WT and agr bacteria were prepared as described (7).
Air Pouch Infection Model. Pouches created by the injection of air
(7) were infected with 100 l of early exponential phase WT or
agr bacteria. After 4–28 h, the pouch was lavaged (5 ml) and
sonicated, and the kidneys (a measure of blood stream metas-
tasis) were homogenized and sonicated before colony-forming
unit (cfu) evaluation (7). The intracellular viable cfu (25) in the
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pouch lavage was determined after killing the extracellular
bacteria by incubating the lavage with 1 gml recombinant
lysostaphin (Sigma) for 30 min at room temperature before
washing and sonication in PBS0.1% Triton X-100. This proce-
dure reduced 107 WT bacteria per ml of buffer by5 logs in the
presence or absence of 106 uninfected murine macrophages. In
vivo promoter activation was measured as the percentage of
bacteria with an MCF of 20 (GFP) and the average fluores-
cence of the GFP bacteria (MCF) (7). Lavage neutrophil
percentage and number were determined as described (25).
Morbidity was measured as weight loss after infection (7).
Injections directly into the pouch to modify in vivo quorum
sensing included the following: 100 l of either 1 M AIP or
oxidized AIP at the time of infection for collection at 4 h and 100
l of either 100 mM N-acetyl methionine (NAM) (Sigma) or
vehicle control (sterile, endotoxin-free saline or PBS) at 24 h for
collection at 28 h.
Oxidant Treatment of AIP. The type I AIP was synthesized (26) and
stored at 100 M in DMSO at 70°C. H2O2 and HOCl (Sigma)
and purified human MPO (Calbiochem) or bovine lactoperox-
idase (Sigma) were diluted with PBS or chloride-free phosphate
buffer (pH 7.4) and incubated with AIP at 37°C for 30 min.
HOCl concentration was determined by its absorbance at 292 nm
(pH 12, 292  350 M1cm1) (27). S-nitrosoglutathione
(GSNO) was synthesized as described (28). Reagent peroxyni-
trite (ONOO) was synthesized in a quenched flow reactor (29)
and stored at 70°C in 1.5 M NaOH, and its concentration was
calculated by its absorbance at 302 nm (302 1,670 M1cm1).
The reactions were carried out in sterile microfuge tubes in 40-l
volumes and contained 2.5 M AIP or a control peptide of
similar size, 2.5 M H2O2, 25 nM MPO, 2.5 M HOCl in the
appropriate buffer, 1 M–10 mM GSNO, or 50–500 M
ONOO diluted into 0.3 M NaOH. To neutralize the base
concentration necessary to maintain the activity of ONOO
(29), an equivalent volume of an acidic phosphate buffer was
included to bring the pH to 7.4 during the AIP treatment. AIP
exposed to the acidbase only was included as a control. NAM
at 0.25–250 M was included to demonstrate protection from
oxidation. Residual oxidants were scavenged by the addition of
100 l of 100 M NAM andor catalase (780 units, Worthing-
ton) before addition to the bacterial reporter assay or injection
into the air pouch.
In Vitro RNAIII Promoter Activation. Early exponential-phase bac-
teria (107 cfu) containing the RNAIII promoter-GFP construct
were cultured as described (7) in the presence or absence of the
following: 100 nM AIP or oxidant-treated AIP (1:25 final
dilution), 100 nM control peptide, 20% WT supernatant, or 20%
agr supernatant in 1 ml of broth. After 3 h, the bacteria were
processed for flow cytometry. RNAIII promoter activation was
measured as the mean fluorescence of the entire population
(MCF) (7). Colony counts were performed to control for
residual effects of the reagents used to oxidize the AIP and
quench the oxidants. A direct effect of oxidants on GFP fluo-
rescence was determined by incubation of fluorescent bacteria
with 10 M HOCl or H2O2 for 30 min at 37°C before flow
cytometry. To control for direct effects of NAM on RNAIII
promoter activation, 100 M NAM was included during broth
culture (3 h and overnight), and the magnitude of RNAIII
promoter activation was determined by flow cytometry.
MS. For quantitative measurements, 10.0 l of AIP samples
generated as described above were analyzed by using a QSTAR
Pulsar I mass spectrometer (Applied BiosystemsMDS Sciex)
coupled with LC Packings Ultimate microcapillary LC system
(Dionex) by using a PepMap C18 column (3 m, 100 Å, 75 m
i.d., 15-cm length). A 10-m i.d. PicoTip nanospray emitter (New
Objective, Woburn, MA) was used with a spray voltage set
between 1,800–2,100 V. AIP tandem MS fragmentation (30)
sequencing of ions 961 and 977 was performed by using the
QSTAR oMALDI source with a laser power of 5%, multichan-
nel panel of 2,225, and a collision active dissociation gas of 55.
Peptide samples for oMALDI analysis were further purified
and plated by using C18 ZipTips (Millipore) and eluted with
4.0 l of 50% 0.1% trif luoroacetic acid50% acetonitrile solu-
tion saturated with recrystallized -cyano-4-hydroxycinnamic
acid (10 mgml).
Statistical Evaluation. Data are depicted as the mean SEM, and
statistical significance was determined by the Mann–Whitney U
test for nonparametrics.
Results
Phagocyte-Derived Oxidants Are Essential for Control of Quorum
Sensing-Dependent but Not Quorum Sensing-Independent S. aureus
Infection. To determine whether quorum sensing is targeted by
phagocyte-derived oxidants as a defense mechanism against S.
aureus infection, we infected NADPH oxidase-, MPO-, and
INOS-deficient mice with either quorum sensing-sufficient WT
bacteria or an agr mutant deficient in quorum sensing. We used
an air pouch model of skin infection that mimics systemic
staphylococcal infection in humans initiated as a cutaneous or
s.c. abscess (31) and in which bacteremia and metastatic infec-
tion follow agr-dependent RNAIII production (7). We quanti-
fied quorum sensing in vivo by infecting with early exponential
phase bacteria containing an RNAIII promoter-GFP construct
and measuring induction of both the percentage of fluorescent
bacteria and their magnitude of fluorescence over time (7, 8, 24).
At a time after infection (24 h) and dose of WT bacteria (2 
107) that result in negligible RNAIII promoter activation in WT
mice (Fig. 1A), bacteria isolated from the pouch of gp91phox
/
mice that lack functional NADPH oxidase (18) demonstrated
significant RNAIII promoter activation (Fig. 1 A). Activation of
the promoter for  hemolysin, a downstream target of RNAIII
(15), also increased in infected gp91phox/ mice, demonstrating
that elevation of RNAIII levels up-regulated virulence factor
gene expression (Fig. 6, which is published as supporting infor-
mation on the PNAS web site). No RNAIII promoter activation
was demonstrable in mice infected with agr-deficient bacteria (7)
(data not shown). Consistent with this difference, both the
bacterial burden (total and intracellular viable cfu per ml of
lavage and both kidneys) and morbidity (weight loss) were
increased in gp91phox/ (Fig. 1B). The appearance and behavior
of the mice also differed; the gp91phox/ mice demonstrated
clinical signs of systemic infection, including lethargy, piloerec-
tion, inappetance, and impaired ambulation whereas the WT
mice ate, drank, and groomed normally.
MPO in phagosomes and secreted extracellularly uses a prod-
uct of the NADPH oxidase, H2O2, in the presence of chloride to
generate HOCl, the oxidant primarily implicated in host defense
against S. aureus infection (20). MPO/ mice were more
susceptible to infection with WT bacteria as demonstrated by
increased RNAIII promoter activation, bacterial burden, and
morbidity (Fig. 1 A and B). However, the magnitude of the defect
was reduced compared with gp91phox/ mice. The primary
product of the oxidase, superoxide anion, combines with NO•
generated by INOS to create peroxynitrite (ONOO), an un-
stable, short-lived powerful oxidant speculated to compensate
for HOCl in MPO deficiency (20). INOS/ mice were more
susceptible to WT infection (Fig. 1B), but the defect was minimal
compared with either the gp91phox/ or the MPO/ mice. At
a higher dose (3.3  107), we observed greater differences
between WT and INOS/ mice (data not shown). These data
indicate that products of all of these phagocytic enzymes are
important at this time point for control of infection with quorum
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sensing-sufficient S. aureus and suggest that activation of the
oxidase in the absence of either MPO or INOS generates
partially protective oxidants for control of quorum sensing-
dependent infection.
If products of these enzymes are primarily important for
controlling infection by suppressing quorum sensing at this early
time point, mice that lack these enzymes should have equivalent
host defense against agr-deficient S. aureus as WT mice. Al-
though agr-deletion mutants are less virulent in several models,
they cause serious infection and death when given at increased
inocula (7, 16). We infected mice with a dose (0.7–1  108 cfu)
that caused moderate morbidity in WT mice (7). Neither the
bacterial burden nor the amount of weight lost was significantly
increased in either gp91phox/, MPO/ mice, or INOS/ mice
(Fig. 1C). In fact, the MPO/and INOS/ mice lost less weight
than WT mice. The similarity of the response was also observed
in the appearance and behavior of the mice. These data indicate
that expression of NADPH oxidase, MPO, or INOS is critical
for control of infection with quorum-sensing but not quorum
sensing-deficient S. aureus early in the course of infection.
H2O2-MPO-Halide System and ONOO Inhibit AIP-Induced RNAIII Pro-
moter Activation in Vitro. We investigated products of these
phagocytic enzymes for their ability to inactivate the octapeptide
thiolactone virulence autoinducer. Incubation of early exponen-
tial phase, nonfluorescent WT bacteria with either 100 nM AIP,
but not a control peptide, or supernatant from WT bacteria, but
not supernatant from agr-deficient bacteria, induced significant
RNAIII promoter activation by 3 h (data not shown). Qualita-
tively similar data were obtained with the type I AIP methicillin-
resistant S. aureus strain COL that contained the RNAIII-GFP
(24) construct, verifying that the ability of this AIP to activate
RNAIII was not exclusive to strain RN6390 (data not shown).
We exposed AIP to various oxidants vs. PBS before inclusion in
the reporter assay. Neither MPO nor H2O2 affected the function
of the AIP. However, inclusion of both in the presence of
chloride but not in its absence completely ablated AIP biologic
activity (Fig. 2A) by 30 min (Fig. 2B). Salivary lactoperoxidase
was substituted for MPO with equivalent results (data not
Fig. 1. Comparison of WT, gp91phox/, MPO/, and INOS/mice for in vivo
RNAIII promoter activation, bacterial burden, and morbidity 24 h after infec-
tion with either quorum sensing-sufficient or -deficient S. aureus. (A and B) WT
(n  29), gp91phox/ (n  10), MPO/ (n  8), and INOS/ (n  8) mice
infected with 2  107 WT[RNAIII-GFP] were compared for the magnitude of
RNAIII promoter activation expressed by bacteria isolated from the pouch
lavage (WTblack line; gp91phox/blue line; MPO/ red line; INOS/
green line) (A) and for the total bacterial burden in the lavage, the intracel-
lular viable bacteria in the lavage, the bacterial burden in the kidney, and
weight loss (B). (C) WT (n  24), gp91phox/ (n  8), MPO/ (n  7), and
INOS/ (n  8) mice infected with 0.7–1.0  108 agr[RNAIII-GFP] were
compared for the total bacterial burden and the intracellular viable bacteria
per ml of lavage, the bacterial burden in the kidney, and weight loss. In this
model, there is no RNAIII promoter activation in the absence of agr (7). ***, P
0.001; **, P  0.01; *, P  0.05.
Fig. 2. Oxidant inhibition of AIP-induced RNAIII promoter activation in vitro.
Type I AIP was incubated with either H2O2-MPO-Cl generated oxidants (A, B,
and C) or ONOO (D and E) as compared with buffer controls to determine
effect on biologic activity (A and E), kinetics of inactivation (B), dose–response
of inactivation (D), and the ability of NAM to protect against the loss of
biologic activity (C and E, respectively). RNAIII promoter activity was measured
at 3 h (MCF of entire population) after incubation of early exponential phase,
nonfluorescent WT[RNAIII-GFP] bacteria with 100 nM native or modified AIP.
Data represent a minimum of three determinations.











shown). These data indicate that peroxidase production of HOCl
is sufficient for inactivation of AIP.
Because methionine is a target of HOCl oxidation (32) and
this AIP contains a methionine (4), we included the HOCL
scavenger, NAM, during inactivation of AIP with equimolar
HOCl or H2O2 plus MPO and chloride. Both oxidants reduced
AIP activity with enzymatic oxidant generation, resulting in a
complete loss of activity (Fig. 2C). Higher concentrations of
HOCl totally inactivated AIP activity. AIP activity was pro-
tected by including NAM at a 10–100 fold excess (Fig. 2C). The
oxidants did not affect the f luorescence of GFP because
incubation of f luorescent bacteria with HOCl or H2O2 did not
inhibit either the percentage or the magnitude of f luorescence
(data not shown). In addition, the results could not be
explained by differences in cfu during the 3-h incubation
because the log cfus ranged from 8.47 to 8.52 under all
conditions, demonstrating equivalent bacterial growth inde-
pendent of AIP treatment (Fig. 7, which is published as
supporting information on the PNAS web site). These data
indicate that products of the MPO-H2O2-halide system inac-
tivate the biologic activity of the secreted autoinducer neces-
sary for quorum sensing in S. aureus.
The partial protection of the MPO/ mice as compared
with the gp91phox/ mice suggested that an oxidant other than
HOCl could compensate for inactivation of the autoinducer
(20). Inclusion of the NO• donor, S-nitrosoglutathione, from
1 M to 10 mM in the reaction had no effect on AIP-induced
RNAIII promoter activation (data not shown). In contrast, the
highly reactive oxidant ONOO reduced AIP activity in a
dose-dependent fashion (Fig. 2D) that was prevented by the
inclusion of 250 M NAM (Fig. 2E). As with the MPO-H2O2-
halide system, inactivation occurred at neutral pH, consistent
with known oxidation of methionine sulfhydryls by ONOO
(29), and had no effect on bacterial growth in the reporter
assay after scavenging residual oxidant. These data indicate
that HOCl and ONOO can inhibit AIP biologic function.
Oxidation of the C-Terminal Methionine Inactivates AIP, and Inclusion
of NAM Protects It from Oxidation. We determined potential
modifications in mass by MS analysis of AIP treated with
oxidants in the presence and absence of NAM. Native func-
tional AIP had a masscharge ratio (mz) of 961 that increased
to 977 after incubation with equimolar HOCl (Fig. 3A), a
treatment that reduced AIP activity (Fig. 2C). The 16 mz
increase was prevented in the presence of NAM (Fig. 3A), a
condition that retained activity (Fig. 2C). When we evaluated
the percentage of AIP in either the native or oxidized form
over multiple experiments, incubation of AIP with MPO plus
H2O2 in the presence of chloride but not in its absence resulted
in a significant increase in the oxidized form (977) (Fig. 3B).
An equivalent result was obtained with HOCl and was pre-
vented by the inclusion of NAM (Fig. 3B). Treatment of native
AIP with OONO at a concentration that reduced activity by
60%, generated major species at 961 (native) and 977 (one
oxygen atom) (Fig. 3C). Minor species at 993 (two oxygen
atoms), 1,006 (NO2 only), and 1,022 (O plus NO2) were also
observed. Inclusion of NAM at a concentration that protected
AIP activity (Fig. 2E) prevented generation of peaks at 977,
993, and 1,022 but not the peak at 1,006 (Fig. 3C). Quantifi-
cation of the percentage of AIP containing either oxygen or
NO2 modifications demonstrated that NAM primarily affected
the generation of oxygen-modified species without an effect on
the addition of NO2 (Fig. 3D). These data indicate that the
addition of oxygen by the MPO-H2O2-Cl system or by
ONOO to the type I AIP inhibits its activity.
Because NAM prevented oxidant inactivation of AIP activ-
ity and protected against oxidation, oxidation of the C-
terminal methionine was most likely responsible for the loss in
function (32). To assign the site of AIP oxidation, we subjected
the native (961) and oxidized (977) forms to tandem MS
fragmentation (y1–y7) (30). The 16 mz increase was observed
only in the 977 fragments that contained the methionine
residue (e.g., fragment y5) whereas the same fragments in the
961 spectra were 16 mz less (Fig. 8, which is published as
supporting information on the PNAS web site), indicating that
oxidation of the C-terminal methionine is responsible for the
loss in biologic activity.
Exogenous Native AIP but Not Oxidized AIP Enhances RNAIII Promoter
Activation Independently of Bacterial Burden in gp91phox/ but Not
WT Mice. RNAIII promoter activation should be increased by
the exogenous administration of native AIP but not oxidized
AIP in NADPH oxidase-deficient mice. We infected WT and
gp91phox/ mice with WT bacteria in the presence of either
native AIP or AIP inactivated in vitro by the MPO-H2O2-Cl
system, and, after 4 h, the percentage of f luorescent bacteria
in the pouch lavage from gp91phox/ mice treated with native
AIP increased significantly (Fig. 4 A and B). No effect was
observed in the WT mice. Neither native AIP nor oxidized
AIP affected either the bacterial burden or the minimal
morbidity (weight loss) (Fig. 4 C and D). These data demon-
strate that, in the absence of NADPH oxidase, exogenous
administration of biologically functional AIP can increase the
percentage of S. aureus undergoing quorum sensing indepen-
dently of any effect on bacterial burden at the site of infection.
Fig. 3. MS analysis of AIP after inhibition by reactive oxidants. The mz of AIP
modified by either HOCl with or without NAM (A) or ONOOwith or without
NAM (C) are depicted. The percentage of native AIP, oxidized AIP, or nitrated
AIP in the presence and absence of NAM is shown for HOCl (B) and ONOO (D).
Data represent a minimum of three determinations.
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Exogenous NAM Enhances RNAIII Promoter Activation in Vivo Inde-
pendently of Bacterial Burden in WT but Not gp91phox/ Mice.
Because NAM protected AIP from oxidant inactivation, it
should increase quorum sensing in vivo in WT mice but not in
oxidase-deficient mice. We injected NAM into the pouch 24 h
after infection with a dose of WT S. aureus that results in
submaximal RNAIII promoter activation and concomitant mor-
bidity in each mouse strain (7) (Fig. 1 A and B). After 4 h, the
bacteria isolated from the NAM-treated WT, but not the
NAM-treated gp91phox/ mice, had significantly increased
RNAIII promoter activation compared to the vehicle control
(Fig. 5 A and B). The increased bacterial quorum sensing in WT
mice did not derive from an increase in bacterial burden in the
lavage (Fig. 5C). However, weight loss was significantly in-
creased by NAM, indicating that RNAIII-up-regulated viru-
lence factor expression-enhanced morbidity in WT mice inde-
pendently of an increase in bacterial burden at the site of
infection (Fig. 5D). Consistent with the partial protection of
MPO/ and INOS/ mice for defense against quorum-sensing
bacteria (Fig. 1 A and B), NAM treatment of these mice
enhanced the magnitude of quorum sensing (data not shown).
These data indicate that NAM is able to quench the oxidants that
suppress in vivo quorum sensing. Moreover, they demonstrate
that phagocyte-derived oxidants contribute to innate immunity
early in infection by inhibiting density-dependent virulence.
Discussion
The quorum-sensing communication system in S. aureus uses a
peptide pheromone to trigger a virulence transcriptome (10, 12,
15) that contributes to morbidity and mortality. We show here
that the type I peptide is inactivated by oxidants, including HOCl
and ONOO, whose production depends on the phagocyte
NADPH oxidase (20). The inactivation is caused by oxidation of
the C-terminal methionine in this peptide and is prevented both
in vitro and in vivo by the scavenger NAM. ONOO exposure
also generates nitrated species (Fig. 3C), and the biologic
significance of this modification in the absence of oxidation is
presently unknown. Even though the methionine is not essential
for the function of this AIP (33), our data confirm the loss of
biologic activity observed with the methionine sulfoxide form of
this peptide purified from culture supernatants (34). This finding
suggests that oxidation may alter either the conformation or
polarity of the peptide so its interaction with the bacterial
receptor agrC is impaired. Consistent with this possibility,
oxidized AIP is not a competitive antagonist of native AIP in
our RNAIII promoter assay (J.M.R. and H.D.G., unpublished
observations).
Phagocyte-derived oxidants are important effectors of innate
immunity and could contribute to host defense against S. aureus
infection by numerous mechanisms. Our data demonstrate that
a major role of neutrophil-derived oxidants in early host defense
against S. aureus infection is the suppression of quorum sensing
and its contribution to virulence independently of an effect on
bacterial burden (Figs. 1, 4, and 5). This finding suggests that the
known role of oxidants in bacterial killing and clearance is less
demonstrable at a point where quorum sensing is optimal.
However, this may not be the case later in the infection after
quorum sensing has occurred, as suggested by the impaired
clearance of S. aureus from peritoneal abscesses in gp91phox/
mice 7 days after infection (18). In addition, the equivalent host
defense against non-quorum-sensing infection between WT and
gp91phox/ mice (Fig. 1C) suggests that compensatory inflam-
matory mechanisms up-regulated in NADPH oxidase-deficient
neutrophils (22) can compensate for infection control in the
absence of the virulence factors up-regulated by RNAIII (15).
Whereas our present data apply only to the type I AIP, exami-
nation of the sequences and structures of other bacterial autoin-
ducers, including peptides, acyl homoserine lactones, and the
furanosyl borate diester (AI-2), reveals multiple potential targets
for oxidation and nitration, including residues within two of the
other three AIPs of S. aureus (2, 3). Therefore, the mechanism we
Fig. 4. Effect of exogenous AIP as compared with oxidized AIP on in vivo
RNAIII promoter activation, bacterial burden, and morbidity in WT and
gp91phox/mice 4 h after infection with quorum sensing-sufficient S. aureus.
WT and gp91phox/ mice were infected with 2  107 WT[RNAIII-GFP] in the
presence of either native (n 8) or oxidant-modified, biologically inactive AIP
(n  8). Representative flow cytometry profiles of bacteria isolated from the
pouch lavage (A), the percentage of GFP bacteria (B), the total and intracel-
lular bacterial burden per ml of lavage (C), and weight loss (D) are depicted.
**, P  0.01.
Fig. 5. Effect of NAM on in vivo RNAIII promoter activation, bacterial
burden, and morbidity in WT and gp91phox/ mice 28 h after infection with
quorum sensing-sufficient S. aureus. WT mice infected with 4107 WT[RNAIII-
GFP] were given PBS (n 12) or NAM (n 12) and gp91phox/ mice infected
with 1.75 107 WT[RNAIII-GFP] were given PBS (n 11) or NAM (n 7) 24 h
after infection. Representative flow cytometry profiles of bacteria isolated
from the pouch lavage (A), the MCF of the GFP bacteria (B), the total and
intracellular bacterial burden per ml of lavage (C), and weight loss (D) are
depicted. ***, P  0.001; **, P  0.01.











have described here for innate control over bacterial communica-
tion could apply broadly to other bacterial infections that depend
on quorum sensing for optimal virulence. Furthermore, the recent
description of enzymatic degradation of a Pseudomonas aeruginosa
autoinducer by human airway epithelia (35) suggests that multiple
effectors of innate immunity may contribute to control of patho-
genic bacterial communication.
S. aureus is primarily a commensal colonizing a third of the
population at any time (31). Our data suggest that oxidant-
mediated suppression of quorum sensing contributes to the high
level of resistance of colonized hosts to infection with this
pathogen and thus provides a barrier against quorum sensing-
dependent virulence. This possibility has several implications for
human infection. First, infection may occur primarily in hosts
with a defect in this barrier. This result is likely for hospital-
acquired infections that develop in patients with severe under-
lying diseases (36) where S. aureus behaves as an opportunistic
pathogen. Second, S. aureus could subvert inactivation of the
autoinducer either by producing an AIP that is resistant to
oxidant attack or by gaining access to a host niche where
phagocyte-derived oxidants cannot penetrate. For example, the
amino acid sequence of the type 3 AIP (33) suggests that it may
be fairly resistant to oxidant inhibition. This resistance could
help explain the emergence in immunocompetent hosts of severe
community-acquired infections caused primarily by agr group 3
strains (37). Thus, S. aureus may be evolving to subvert oxidant
inactivation of quorum sensing. In addition, we have shown that
RNAIII promoter activation is enhanced in fibrin(ogen)-
clumped bacteria in WT mice (7), suggesting that, in this niche,
the bacteria undergoing quorum sensing are protected from
phagocyte-derived oxidants. Finally, S. aureus growth on im-
planted catheters and in some anatomic sites does not lead to
detectable RNAIII production (7, 9), suggesting that human
infection could occur in the absence of the agr effector.
Here we have described a previously unrecognized role for the
NADPH oxidase in innate immunity. Because quorum quench-
ing is being pursued as a therapeutic goal (4, 38), understanding
the contribution of innate immunity to quorum quenching and
how pathogens avoid it could augment drug design that targets
virulence pheromones for inactivation.
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